Drug Type Small molecule drug |
Synonyms 4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid, 4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester, BNX + [21] |
Target |
Action modulators |
Mechanism SCNA modulators(Sodium channel alpha subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (07 Jun 1966), |
Regulation- |
Molecular FormulaC17H29ClN2O3 |
InChIKeyPRGUDWLMFLCODA-UHFFFAOYSA-N |
CAS Registry5987-82-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01768 | Benoxinate Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Excessive tearing | Japan | 26 Dec 1972 | |
Anesthesia | United States | - | - |
Not Applicable | 114 | Small incision lenticule extraction+Tobramycin+Proxymetacaine 0.5%+Oxybuprocaine 0.4%+dexamethasone+Ofloxacin | ywajwqlomu(xwamncpowo) = jvvrcjpjeo eevtzlmasw (mjrdjukaae, xgoomjxnzb - rlrjljepnq) View more | - | 23 Apr 2024 | ||
Not Applicable | - | 42 | egnnugoibr(exglhjqmuw): P-Value = 0.029 View more | Positive | 01 Sep 2021 | ||
Not Applicable | 50 | Tetracaine/Oxybuprocaine | kzzchdvisu(wmpvgrwqiu) = ohtfkqxcsb zkebrnqwyp (nqqsoptszz ) | Positive | 01 May 2006 | ||
kzzchdvisu(wmpvgrwqiu) = llyfadlwrk zkebrnqwyp (nqqsoptszz ) |